IDRA 21

Discontinued Product

1219 has been discontinued.

View all AMPA Receptors products.
说明: Inhibits AMPA desensitization
化学名: 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (4)

生物活性 for IDRA 21

Inhibits AMPA receptor desensitization and enhances cognition by a related mechanism. More able to cross the blood-brain barrier than cyclothiazide (Cat. No. 0713).

技术数据 for IDRA 21

分子量 232.68
公式 C8H9ClN2O2S
储存 Store at RT
纯度 ≥98% (HPLC)
CAS Number 22503-72-6
PubChem ID 3688
InChI Key VZRNTCHTJRLTMU-UHFFFAOYSA-N
Smiles CC1NC2=C(C=C(Cl)C=C2)S(=O)(=O)N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for IDRA 21

分析证书/产品说明书
选择另一批次:

按产品操作查看相关产品

查看全部 AMPA Receptor Inhibitors

关键词: IDRA 21, IDRA 21 supplier, inhibitors, inhibits, AMPA, receptor, desensitization, desensitisation, Glutamate, Receptors, iGlur, Ionotropic, IDRA21, 1219, Tocris Bioscience

篇 IDRA 21 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 IDRA 21 的引用文献。

IDRA 21 的评论

目前没有该产品的评论。 Be the first to review IDRA 21 and earn rewards!

Have you used IDRA 21?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.